| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT00285857 | Breast Cancer | Drug: Lovastatin | Stanford University | Phase 2 | 2005-11-01 | 2017-01-19 |
| NCT00580970 | Prostate Cancer | Drug: lovastatin | Virginia Commonwealth University|Hunter Holmes Mcguire Veteran Affairs Medical Center | Phase 2 | 2007-04-01 | 2016-09-28 |
| NCT00585052 | Ovarian Cancer | Drug: Lovastatin and Paclitaxel | University of Iowa | Phase 2 | 2003-08-01 | 2010-12-20 |
| NCT01527669 | Healthy Subjects | Drug: LipoCol Forte capsules|Drug: Lovastatin Tablet | National Taiwan University Hospital|National Science Council, Taiwan | Phase 4 | 2012-02-01 | 2012-07-09 |
| NCT01478828 | Prostate Cancer | Drug: Lovastatin | Sidney Kimmel Comprehensive Cancer Center | | 2012-03-01 | 2015-10-13 |
| NCT01346670 | Healthy Volunteer | Drug: LipoCol and Mevacor | Taipei Medical University WanFang Hospital | Phase 4 | 2006-10-01 | 2011-05-01 |
| NCT00963664 | Melanoma|Malignant Melanoma | Drug: lovastatin|Drug: interferon alfa-2b | NeoPlas Innovation | Phase 2 | 2009-12-01 | 2009-09-04 |
| NCT00700921 | Chronic Obstructive Pulmonary Disease (COPD) | Drug: Lovastatin|Drug: Placebo | National Jewish Health|National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 | 2008-04-01 | 2012-11-26 |
| NCT00302952 | Rheumatoid Arthritis | Drug: Lovastatin|Drug: Placebo | National Institute of Allergy and Infectious Diseases (NIAID)|Autoimmunity Centers of Excellence | Phase 2 | 2006-08-01 | 2016-09-13 |
| NCT02642653 | Fragile X Syndrome|Genetic Diseases | Drug: Lovastatin|Drug: Placebo | Randi J. Hagerman, MD|University of California, Davis | Phase 4 | 2016-01-01 | 2016-10-24 |
| NCT00352599 | Neurofibromatosis 1 | Drug: Lovastatin|Drug: Lovastatin|Drug: placebo pill | University of California, Los Angeles | Phase 1 | 2009-09-01 | 2016-11-18 |
| NCT00584012 | Any Cancer|Breast Cancer | Drug: Lovastatin and Docetaxel | University of Iowa | Phase 1|Phase 2 | 2004-04-01 | 2009-06-18 |
| NCT02603770 | Lipid Metabolism Disorder | Drug: XueZhiKang|Drug: Lovastatin | Luye Pharma Group Ltd. | Phase 1 | 2015-11-01 | 2016-12-02 |
| NCT00583102 | Acute Myeloid Leukemia | Drug: Lovastatin and Cytarabine | University of Iowa | Phase 1|Phase 2 | 2001-06-01 | 2010-12-20 |
| NCT01110642 | Syndromic Ichthyoses|CHILD Syndrome|Smith Lemli Opitz Syndrome|Conradi Syndrome | Drug: Lovastatin | Northwestern University | Phase 2 | 2011-07-01 | 2015-05-15 |
| NCT00243880 | Stroke | Drug: lovastatin | Columbia University | Phase 1 | 2005-09-01 | 2016-05-05 |
| NCT00689806 | Severe Persistent Asthma | Drug: Lovastatin|Drug: Placebo | University of Chicago | Phase 1|Phase 2 | null | 2013-06-20 |
| NCT00462280 | Precancerous Condition|Stage 0 Melanoma|Stage I Melanoma|Stage II Melanoma | Drug: lovastatin|Other: placebo|Procedure: biopsy|Procedure: laboratory biomarker analysis | National Cancer Institute (NCI) | Phase 2 | 2007-05-01 | 2014-10-24 |
